Health care stocks were retreating Thursday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) 0.2% lower.
The iShares Biotechnology ETF (IBB) rose 0.1%.
In corporate news, Walgreens Boots Alliance (WBA) agreed to pay $2.8 million to settle allegations that it violated federal, Massachusetts and Georgia laws by submitting inflated prices for certain generic medications to the states' Medicaid programs, the US Attorney's Office for the District of Massachusetts said. Walgreens shares rose 0.7%.
23andMe (ME) shares surged 50% after a court authorized the company to start an asset sale process through a Chapter 11 plan or pursuant to Section 363 of the US Bankruptcy Code.
Abbott Laboratories (ABT) shares rose 3% after the company said Thursday it has received CE Mark certification in Europe for its Volt pulsed field ablation system to treat patients with heart rhythm disorders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.